Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Waldencast plc - Class A Ordinary Share
(NQ:
WALD
)
1.615
-0.055 (-3.29%)
Streaming Delayed Price
Updated: 11:19 AM EDT, Jul 29, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Waldencast plc - Class A Ordinary Share
< Previous
1
2
3
4
5
6
7
8
9
Next >
Obagi Medical Announces FDA Approval of Obagi® saypha® ChIQ™ Injectable Hyaluronic Acid Gel
June 15, 2026
Approval Further Expands Obagi Medical’s Injectable Portfolio and Strengthens Its Position as a Leading Dermatological Megabrand
From
Waldencast plc
Via
GlobeNewswire
Which stocks are experiencing notable movement on Monday?
↗
June 01, 2026
Via
Chartmill
Waldencast Announces Sale of Obagi Medical to Bridgepoint
June 01, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting
May 15, 2026
Data from the ALOHA Program and NU-GEN™ Cellular Renewal Serum Showcase Results to Help Drive Practice Success
From
Waldencast plc
Via
GlobeNewswire
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience
May 14, 2026
A multi-city pop-up introducing consumers to the future of skincare and longevity innovation
From
Waldencast plc
Via
GlobeNewswire
Unusual volume stocks are being observed in Thursday's session.
↗
April 30, 2026
Via
Chartmill
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin*
April 30, 2026
Sun Shield™ Mineral UV Barrier Protect Broad Spectrum SPF 40 delivers advanced mineral protection with skincare benefits for daily defense
From
Waldencast plc
Via
GlobeNewswire
Get insights into the top gainers and losers of Wednesday's pre-market session.
↗
April 29, 2026
Via
Chartmill
Waldencast announces conclusion of SEC investigation
April 28, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Introduces NU-GEN™ Cellular Renewal Serum Designed to Visibly Rewind Skin’s Age and Restore Visible Youthfulness
March 24, 2026
The clinically proven formula pairs NAD+ with its precursors to replenish skin cells and address nine signs of skin aging for healthier, more resilient-looking skin
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and ProMD Announce Collaboration in the ALOHA Program to Advance Clinical Evidence with Obagi® saypha® MagIQ™
March 19, 2026
ProMD’s multi-location physician led network will participate in Obagi’s ALOHA Program as part of a structured evaluation of MagIQ and integrated skincare protocols to providers across multiple states
From
Waldencast plc
Via
GlobeNewswire
Waldencast Reports Q4 2025 and FY 2025 Financial Results
March 13, 2026
From
Waldencast plc
Via
GlobeNewswire
Waldencast plc Announces Fourth Quarter and Fiscal Year 2025 Earnings Date
March 11, 2026
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 27, 2026
Schweiger selected as a leading dermatology platform partner due to its commitment to clinical excellence, rapid access to care, and dissemination across its extensive national network of practices
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and It’s a Secret Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 25, 2026
It’s a Secret Med Spa selected as a premier luxury med spa partner due to its commitment to excellence, personalized luxury aesthetic experiences, and outstanding patient results across its growing...
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Aesthetic Record Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 17, 2026
Aesthetic Record selected as a leading aesthetics EMR and practice management partner due to its commitment to technology innovation, operational efficiency, and supporting thousands of aesthetic...
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 06, 2026
DermFx selected as a leading regional med spa partner due to its commitment to exceptional patient care, aesthetic innovation, and excellence across Southern California practices
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
February 05, 2026
Moxie selected as a leading aesthetic practice software and support partner for its commitment to innovation, compliance, and empowering aesthetic entrepreneurs
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect
February 03, 2026
The dermatologist-tested duo pairs gentle chemical resurfacing with daily hydration and SPF protection for visibly smoother lips
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and VIO Med Spa Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 30, 2026
VIO Med Spa selected as a key med spa franchise partner for its commitment to clinical excellence, innovation, and nationwide scalable aesthetic care
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Next Health Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 28, 2026
Next Health selected as a leading wellness and longevity partner given its innovative approach to personalized aesthetics and health optimization
From
Waldencast plc
Via
GlobeNewswire
UPDATE - Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
January 27, 2026
Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Alpha Aesthetic Partners Announce Their Collaboration in the ALOHA Program to Drive Real-World Evidence with Obagi® saypha® MagIQ™
January 27, 2026
Alpha selected as the first Medspa platform partner given their commitment to innovation, education, and breaking through barriers
From
Waldencast plc
Via
GlobeNewswire
CORRECTION – Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 26, 2026
Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™
January 26, 2026
Platinum selected as the first dermatology platform partner due to its commitment to clinical evidence and dissemination across its network of practices
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Unveils ALOHA Program to Launch Obagi® saypha® MagIQ™ – Pioneering the Largest Real-World Evaluation of a New Hyaluronic Acid Filler
January 21, 2026
Program Designed to Drive Real World, Practice Focused Evidence with Injectables & Skincare
From
Waldencast plc
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
January 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Waldencast plc - WALD
December 30, 2025
From
Pomerantz LLP
Via
GlobeNewswire
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update
November 24, 2025
From
Waldencast plc
Via
GlobeNewswire
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting
November 16, 2025
Obagi® saypha® ChIQ™ data selected as a top 10 cosmetic oral abstract presentation
From
Waldencast plc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
